Zheng Quan Zhi Xing·2025-08-21 16:36Summary of Key Points Core Viewpoint - The incentive plan proposed by Nocera Pharmaceutical Co., Ltd. involves the allocation of restricted stock to various incentive recipients, with a total of 246.7550 million shares being allocated, representing 20.00% of the reserved shares for the plan [1]. Group 1: Incentive Plan Details - The incentive plan includes a distribution of restricted stock among different incentive recipients, with specific allocations detailed in the accompanying table [1]. - The total number of restricted shares granted to other employees, deemed necessary for motivation by the board, is 246.7550 million shares, which constitutes 20.00% of the total reserved shares [1]. - The cumulative number of shares granted to any individual recipient through the company's equity incentive plan will not exceed 1% of the total shares issued by the company at the time of the plan's submission for shareholder approval [1]. Group 2: Compliance and Limitations - The total number of shares involved in all equity incentive plans will not exceed 20% of the total shares issued by the company at the time of the plan's submission for shareholder approval [1]. - The total number of shares that can be issued under all incentive plans will not exceed 10% of the total shares issued by the company at the time of the plan's submission for shareholder approval [1].